drugset / Trial / NCT03453632

Injections of Botulinic Toxin in Plantar Lesions of Localized Epidermolysis Bullosa Simplex

NCT03453632

Phase 2/3 Unknown 25 enrolled University Hospital, Toulouse
RandomizedCrossoverTriple-blindTreatment

Summary

The investigators hypothesize that palmar injections of botulinic toxin, via an inhibition of the sudation, would limit the occurrence of blisters in localized epidermolysis bullosa simplex (LEBS).

Timeline

Start
2018-06-14
Primary completion
2023-09
Completion
2023-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinic toxin Unknown 200 iu Other